What is OneOme?
Headquartered in Minneapolis, Minnesota, OneOme operates at the intersection of biotechnology and healthcare informatics. Co-founded by the Mayo Clinic, the organization provides a comprehensive suite of tools that enable healthcare providers to implement pharmacogenomics—the study of how genes affect a person's response to drugs—into routine patient care. Their platform encompasses everything from high-quality laboratory testing to sophisticated software support, allowing for both individual patient diagnostics and large-scale population health management. By focusing on the reduction of adverse drug events and the improvement of patient outcomes, OneOme has established itself as a critical partner for health systems seeking to modernize their approach to personalized medicine.
How much funding has OneOme raised?
OneOme has raised a total of $4.3M across 4 funding rounds:
Unspecified
$1M
Debt
$2.1M
Private Equity
$530K
Debt
$611K
Unspecified (2015): $1M, investors not publicly disclosed
Debt (2016): $2.1M, investors not publicly disclosed
Private Equity (2016): $530K, investors not publicly disclosed
Debt (2021): $611K featuring PPP
Key Investors in OneOme
Undisclosed Investor
An institutional partner providing capital to support the scaling of pharmacogenomic infrastructure and clinical decision support technologies.
PPP
Public-Private Partnership
Private Equity Partner
An investment firm specializing in growth-stage healthcare companies, providing the necessary capital to transition from research-based models to enterprise-level market solutions.
What's next for OneOme?
With the recent influx of capital, OneOme is poised to accelerate its strategic initiatives, particularly in the expansion of its clinical decision support software and the broadening of its global footprint. The company is expected to prioritize the enhancement of its analytics engine, which is vital for translating genomic insights into real-time clinical interventions. As the healthcare industry continues to shift toward value-based care models, OneOme's focus on reducing the total cost of care through precision diagnostics positions it as a key player in the future of digital health. Future growth will likely involve deeper integration with electronic health record systems and the scaling of its laboratory infrastructure to meet the rising demand for personalized therapeutic guidance.
See full OneOme company page
